Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. [electronic resource]
Producer: 20050707Description: 467-71 p. digitalISSN:- 0268-3369
- Adolescent
- Adult
- Alemtuzumab
- Anemia, Aplastic -- complications
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bone Marrow Transplantation -- adverse effects
- Child
- Cyclophosphamide -- administration & dosage
- Graft Survival
- Graft vs Host Disease -- pathology
- Histocompatibility Testing
- Humans
- Immunosuppression Therapy
- Incidence
- Tissue Donors
- Treatment Outcome
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.